Targeting Death-Associated Protein Kinases for Treatment of Human Diseases: Recent Advances and Future Directions

J Med Chem. 2023 Jan 26;66(2):1112-1136. doi: 10.1021/acs.jmedchem.2c01606. Epub 2023 Jan 16.

Abstract

The death-associated protein kinase (DAPK) family is a member of the calcium/calmodulin-regulated serine/threonine protein kinase family, and studies have shown that its role, as its name suggests, is mainly to regulate cell death. The DAPK family comprises five members, including DAPK1, DAPK2, DAPK3, DRAK1 and DRAK2, which show high homology in the common N-terminal kinase domain but differ in the extra-catalytic domain. Notably, previous research has suggested that the DAPK family plays an essential role in both the development and regulation of human diseases. However, only a few small-molecule inhibitors have been reported. In this Perspective, we mainly discuss the structure, biological function, and role of DAPKs in diseases and the currently discovered small-molecule inhibitors, providing valuable information for the development of the DAPK field.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium-Calmodulin-Dependent Protein Kinases* / chemistry
  • Catalytic Domain
  • Death-Associated Protein Kinases / chemistry
  • Death-Associated Protein Kinases / metabolism
  • Humans
  • Protein Serine-Threonine Kinases* / metabolism

Substances

  • Death-Associated Protein Kinases
  • Protein Serine-Threonine Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases